Real-time myocardial perfusion contrast echocardiography permits simultaneous assessment of wall motion and perfusion by detection of intravascular microbubbles behaving as tracers for blood flow. Assessment of gradual refill of microbubbles into the myocardial microcirculation is the key for evaluation of perfusion with RTP-CE. 4 To date, quantitative and qualitative RTP-CE has not been evaluated in patients with SAH. Our objective was to use RTP-CE in the prospective evaluation of myocardial microvascular function at acute SAH presentation and in subsequent follow-up visits for patients with baseline RWMAs.
Methods

Study Participants
This study was approved by the Mayo Clinic Institutional Review Board, and all patients or next of kin provided signed informed consent. Over a 15-month period, 53 patients presenting to the Neuro-Intensive Care Unit at Saint Mary's Hospital, Rochester, Minnesota, with acute SAH were evaluated for study enrollment. Patients with elevated cardiac biomarkers or abnormal ECG findings were eligible for enrollment. Patients were excluded if there was documented history of preexisting cardiac disease, known hypersensitivity, or contraindication to contrast agent.
Data Collection
The Mayo Clinic electronic record system was used to retrieve patients' characteristics, risk factors, and trig gering factors. Results of tests for cardiac enzymes, ECG data, and hemodynamics at admission were also re corded.
Myocardial RTP-CE
Continuous intravenous infusion of diluted perflutren lipid microspheres (Definity [1.3 ml in 28 ml NaCl], Lantheus Medical Imaging, Inc.) was given at 200 ml/ hour, which maintained a homogeneous contrast enhancement in the myocardium. An ultrasound system (Sonos 7500, Philips Medical Systems Inc.) was used. We performed RTP-CE using power-modulation imaging at a low mechanical index (≤ 0.2). Imaging was performed in the apical 4-, 3-, and 2-chamber and short-axis views. A flash-replenishment technique was used as follows: a high-mechanical index (1.2) "flash" (5-10 frames) was manually triggered to clear myocardial microbubbles, followed by a low-mechanical index (≤ 0.2) imaging for 15 cardiac cycles to observe myocardial microbubbles replenishment.
Echocardiographic Data Analysis
Digitized RTP-CE cine loops were analyzed in 16 segments by 2 independent investigators for qualitative RTP-CE. 2 Wall motion was scored (normal, hypokinetic, akinetic, dyskinetic, or aneurysmal) and the wall motion score index was calculated. Resting myocardial perfusion was considered abnormal when ≥ 2 segments in any of the coronary artery territories exhibited decreased or absent contrast enhancement in the first 5 cardiac cycles after flash. Qualitatively, contrast enhancement in each segment was graded as follows: absent or decreased perfusion, or normal perfusion. Quantification of RTP-CE was done by QLab software (version 5.0, Philips Medical Systems). Time-intensity curves were generated and fitted to monoexponential function: Y = A (1 − e -βt ), where β (in s -1 ) represents the rate of rise in signal intensity (microbubble velocity; MBFV) and A (in dB) represents the peak plateau of video intensity (myocardial blood volume); "A" was subsequently corrected for the blood pool video intensity. An index of MBF was calculated as product of A × β (dB/s). 8 The RTP-CE feasibility was evaluated by reporting the percentage of the analyzable myocardial segments.
Statistical Analysis
Continuous data are reported as the mean ± SD for normally distributed values and in the median and interquartile range for skewed data. Frequencies and percentages were used to report categorical variables. All values are reported with the corresponding 95% CIs. An independent t-test was used to compare continuous variables and a chi-square test for categorical variables. The paired t-test was used to compare quantitative perfusion parameters at baseline with follow-up in the same patients. Stratified analysis based on coronary artery territories was also reported. Interobserver agreement for quantitative myocardial perfusion was evaluated in 5 patients by 2 independent observers, and agreement was assessed using linear regression. In all analyses, 2-sided tests were used and significance was set at p = 0.05. Analysis was performed using SAS software (JMP version 7.0; SAS Insti tute Inc.).
Results
We identified 10 patients (7 females and 3 males, mean age 63.5 ± 10.1 years) with aneurysmal SAH. The median Glasgow Coma Scale score at presentation was 11 (range 4-14). Posterior circulation aneurysms were present in 4 patients whereas anterior circulation aneurysms were present in 6 patients. Aneurysms were treated by endovascular coiling in 8 and clip placement in 2 patients. We documented ECG changes in 90% of patients. Cardiac enzymes were elevated with peak values of troponin T (reference ≤ 0.03 ng/ml) of 0.39 ± 0.27 ng/ml, creatine kinase-MB (reference ≤ 6.2 ng/ml) of 15.05 ± 15.2 ng/ml, and B-type natriuretic peptide (reference ≤ 140.0 pg/ml) of 470.3 ± 213.7 pg/ml. Regional wall motion abnormalities were found in 6 (60%) of 10 patients. The wall motion score index in the RWMA group was 1.87 ± 0.35. The ejection fraction in patients with RWMA was lower than in those with normal wall motion (36 ± 11% vs 60 ± 9%; p < 0.001). Clinical and demographic data at admission are presented in Table 1 .
Echocardiographic RWMAs (hypokinesia and akinesia) were segmental in all 6 patients, involving 51 (53%) of 96 segments. Four patients had characteristic mid-and apical left ventricle RWMA, and 1 patient had marked midventricle RWMA, whereas another had apical aki-nesia only. The individual patterns of echocardiographic RWMAs are shown in Fig. 1 .
Ultrasound contrast agents were administered in all 10 patients, and RTP-CE was successfully performed in all patients within a mean time of 43.5 ± 19.3 hours of SAH diagnosis. The RTP-CE image acquisition time was 7.5 ± 1.2 minutes. There were no immediate or shortterm adverse events associated with the contrast infusion. Qualitative and quantitative RTP-CE analysis was feasible in 147 (92%) of 160 segments (feasibility per 4-chamber view, 2-chamber view, and long-axis view were 93, 88, and 95%, respectively). Of those 51 segments with RWMA, RTP-CE was successfully analyzed in 45 (88%), with lateral segments (in the left circumflex coronary artery distribution) being least feasible.
Normal perfusion by qualitative RTP-CE was reported in all analyzable segments despite RWMAs. In addition, patients presenting with RWMAs had higher quantitative perfusion parameters than those with normal wall motion: mean MBFV of 1.62 ± 0.64 (95% CI 0.94-2.29) compared with 1.08 ± 0.61 (95% CI 0-2.61), respectively, and A × β (MBF) 1.63 ± 0.86 (95% CI 0.72-2.53) compared with 0.99 ± 0.41 (95% CI 0-2.0), respectively. However, these differences were not statistically significant.
Stratified analysis by coronary territory similarly revealed pattern of higher RTP-CE quantitative parameters (A, β, and A × β) in those patients with RWMA than those with normal wall motion Table 2 .
Follow-up RTP-CE studies were obtained in 3 of 6 patients with RWMAs for whom the mean follow-up was 53.7 ± 43 days. Two comatose patients died within 25 days of admission and 1 was lost to follow-up. In those who completed follow-up, RWMAs were seen in 20 segments whereas 28 segments exhibited normal wall motion in the acute setting. Higher β and A × β values were documented in segments with RWMAs (Table 3) . With restoration of normal systolic function, comparable values for β and A × β values were measured in both groups.
Interobserver variability correlation coefficients for A and β parameters were r = 0.748/p = 0.0004 and r = 0.969/p < 0.0001, respectively. Figure 2 upper illustrates normal myocardial perfusion by RTP-CE, despite RWMAs, in a 73-year-old woman who presented with acute SAH and ST-segment and T-wave abnormalities as well as elevated cardiac enzymes. Follow-up RTP-CE demonstrated complete resolution of RWMAs and normal myocardial perfusion. For comparison, we illustrated a persistent myocardial perfusion defect by resting RTP-CE in a patient with ST-segment elevation myocardial infarction (Fig. 2 lower) . 
Discussion
Despite the presence of RWMAs in patients who presented with acute SAH, we found normal microvascular perfusion in all patients. Furthermore, we observed a trend for higher quantitative RTP-CE parameters in RWMA-affected segments. This study highlights the role of RTP-CE as a noninvasive, bedside imaging modality and illustrates the absence of myocardial hypoperfusion at the microvascular level in cardiac dysfunction following SAH. These observations could help provide further insight into the pathophysiological mechanism underlying cardiac dysfunction in patients with SAH.
In only 1 previous animal study has contrast echocardiography been used to evaluate microvascular function in the presence of cardiac dysfunction after SAH; this experimental SAH canine model reproduced the clinical and pathological cardiac lesions of SAH, and similarly, the authors found no myocardial hypoperfusion in segments with transient RWMA. Regional mean MBF measured with radiolabeled microspheres was higher in SAH animals (1.42 ± 1.17 ml/min/g) than in control animals (0.94 ± 0.29 ml/min/g); however, this difference did not reach statistical significance. 10 In our clinical study, we similarly documented normal myocardial perfusion despite RWMA. With quantitative RTP-CE, we confirmed the qualitative observations by measuring higher MBFV and MBF in patients with RWMA compared with those with normal wall motion.
Previous studies evaluating microvascular perfusion with perfusion scintigraphy in patients with SAH have shown conflicting results. In one study, using acquired rest and redistribution planar thallium in 19 patients with SAH, reversible myocardial perfusion defects were present in 32% of patients, but these results may have been confounded by the concomitant presence of coronary artery disease, and the recognized limitations of resolution and partial volume effects with this technique. 7 Other studies have documented normal uptake of methoxyisobutyl iso nitrile (MIBI), indicating normal resting myocardial per fusion. In the same series, metaiodobenzylguanidine (MIBG) scintigraphy showed evidence of sympathetic func tional denervation in 29% of patients with SAH, and the pattern of denervation was global in the majority of patients. 1 A similar observation was reported in a case report in which 99m Tc pyrophosphate myocardial infarct scanning revealed normal findings despite presence of ST-segment elevation and RWMA after SAH. 3 The utility of RTP-CE to assess myocardial perfusion and function qualifies this modality as an ideal noninvasive method for evaluation of myocardial microvascular function in patients with acute SAH. In addition, quantification of MBF provides more objective assessment than qualitative myocardial contrast electrocardiography alone. To date, the current study is the first to report using qualitative and quantitative MBF derived from RTP-CE in the acute phase of SAH. Neurogenic cardiomyopathy may present with global or segmental RWMAs. It remains unclear, but these observations support the possibility that the driving mechanism might be a transient myocardial ischemia associated with transient microvascular dysfunction. The trend toward hyperperfusion in the presence of RWMAs may suggest the possibility of earlier hypoperfusion from coronary artery spasm and subsequent reactive hyperemia. Quantitative RTP-CE measured very soon (< 24 hours) after aneurysmal rupture could potentially be used to explore such a novel hypothesis.
This study is limited mainly by its small number of patients. Nevertheless, the critical condition in patients with acute-phase SAH further hinders prospective recruitment of patients. Another limitation is the absence of a comparison group, the inclusion of which could have increased the validity of the findings. The lack of coronary angiography to anatomically document coronary artery disease is another important limitation, although coronary angiography measures only epicardial and not microvascular function.
Conclusions
We found that RTP-CE readily evaluates microvascular function in patients with SAH. Accordingly, a proposal could be made that patients with SAH who present with cardiac dysfunction during the acute stage occurs in the absence of microvascular dysfunction, as evidenced by normal myocardial perfusion detected with RTP-CE and confirmed quantitatively. Larger-scale studies are needed to explore the pathophysiological mechanisms underlying neurogenic-stunned myocardium.
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